A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents and Young Adults
Sponsor: National Cancer Institute (NCI)
Terminated
Study closed due to low accrual.
Other terminated trials from National Cancer Institute (NCI)
A PHASE1 clinical study on Adolescent and Human Immunodeficiency Virus, this trial is terminated or withdrawn. The trial is conducted by National Cancer Institute (NCI) and has accumulated 29 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
29 versions recorded-
Dec 2024 — Present [monthly]
Terminated PHASE1
Status: Completed → Terminated
-
Sep 2024 — Dec 2024 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Feb 2022 — Jul 2024 [monthly]
Completed PHASE1
-
Nov 2021 — Feb 2022 [monthly]
Completed PHASE1
▶ Show 24 earlier versions
-
Sep 2021 — Nov 2021 [monthly]
Completed PHASE1
-
Jun 2021 — Sep 2021 [monthly]
Completed PHASE1
-
Jan 2021 — Jun 2021 [monthly]
Completed PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE1
-
Sep 2020 — Dec 2020 [monthly]
Completed PHASE1
-
May 2020 — Sep 2020 [monthly]
Completed PHASE1
-
Apr 2020 — May 2020 [monthly]
Completed PHASE1
-
Mar 2020 — Apr 2020 [monthly]
Completed PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Completed PHASE1
-
Dec 2019 — Feb 2020 [monthly]
Completed PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Completed PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Completed PHASE1
-
Sep 2019 — Oct 2019 [monthly]
Completed PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Completed PHASE1
-
Jul 2019 — Aug 2019 [monthly]
Completed PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Completed PHASE1
-
May 2019 — Jun 2019 [monthly]
Completed PHASE1
-
Mar 2019 — May 2019 [monthly]
Completed PHASE1
-
Oct 2018 — Mar 2019 [monthly]
Completed PHASE1
-
Aug 2018 — Oct 2018 [monthly]
Completed PHASE1
-
Jul 2018 — Aug 2018 [monthly]
Completed PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Completed PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .